Dr. Pride Chigwedere is an affiliate of the Harvard AIDS Initiative. He trained and worked as a physician at Harare Central Hospital, Zimbabwe, and then moved to the Harvard School of Public Health where he completed a doctorate in immunology and infectious diseases and post-doctoral training with renowned retrovirologist, Dr. Max Essex. He then joined McKinsey and Company where he has been advising the senior management of top pharmaceutical companies and global health institutions primarily in areas of business strategy and medical affairs. He is the lead author of the paper published in The Journal of Acquired Immune Deficiency Syndromes estimating the human toll of South Africa's AIDS policies, which has received wide publicity including The New York Times, The Guardian, BBC and other leading news organizations around the world.